文献速递消化道肿瘤与早癌消化内镜

结直肠肿瘤形成中的肠道微生物组特征:跨越肿瘤分期与亚型的横断面研究

Gut microbiome signatures in colorectal neoplasia: a cross-sectional study across neoplasia stages and subtypes.
PubMed 文献 · Gut · 2026-10-07

该研究基于COLO-COHORT多中心队列中1762例接受结肠镜检查者的结肠镜前粪便宏基因组,分析肠道微生物组与结直肠肿瘤存在、严重程度及亚型的关联。结果显示,有无肿瘤者间微生物组组成差异虽具统计学显著性但极小(R2=0.0008,p=0.03),仅少数物种和通路与肿瘤弱相关,微生物组联合临床特征对高风险肿瘤分类的预测提升有限(AUC=0.64 vs 0.58)。结论认为肠道微生物组与癌前结直肠肿瘤关联弱且不一致,缺乏稳健微生物特征。

要点

  • 有无肿瘤者间微生物组组成差异显著但效应极小(R2=0.0008)。
  • 仅少数物种和通路与肿瘤弱相关,协变量调整后关联减弱。
  • 微生物组联合临床特征对高风险肿瘤预测提升有限(AUC 0.64 vs 0.58)。

核心结论

  • 肠道微生物组与癌前结直肠肿瘤的关联弱且不一致,未发现稳健的微生物特征。
  • 既往报道的微生物变化可能出现在疾病进展后期,或为结直肠癌的结果而非原因。

研究设计与样本

  • 横断面研究,分析COLO-COHORT多中心研究中1762例接受结肠镜检查参与者的结肠镜前粪便宏基因组。
  • 参与者97%为英国白人,肿瘤按英国胃肠病学会监测指南分类。
  • 采用线性混合效应模型和随机森林分类器评估分类学与功能关联,并调整饮食、临床和生活方式协变量。

主要发现

  • 有无肿瘤者间微生物组组成差异具统计学显著性但极小(R2=0.0008,p=0.03)。
  • Mediterraneibacter faecis、Pseudoruminococcus massiliensis等少数物种及氨基酸生物合成、β-内酰胺耐药等通路与肿瘤弱相关,尤其早期病变(q值<0.05)。
  • 关联总体较弱,协变量调整后减弱。
  • 微生物组联合临床/人口学特征对高风险肿瘤分类的预测能力 modestly 提升(AUC=0.64 vs 0.58)。

关键数值与推荐

  • 微生物组组成差异:R2=0.0008,p=0.03。
  • 少数物种和通路与肿瘤相关:q值<0.05。
  • 预测高风险肿瘤的AUC:联合模型0.64,仅临床/人口学特征0.58。

临床怎么用

  • 当前微生物组特征尚不足以作为癌前结直肠肿瘤的稳健生物标志物。
  • 微生物组联合临床特征对高风险肿瘤分类的增量预测价值有限。

局限性

  • 横断面设计无法推断因果关系。
  • 参与者97%为英国白人,外推性受限。
  • 关联较弱且经协变量调整后减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While colorectal cancer (CRC) has been linked to the gut microbiome, it remains unclear whether specific microbial signatures are detectable in precursor lesions such as adenomatous polyps, serrated lesions or sessile serrated lesions. OBJECTIVE: To assess gut microbiome taxonomic and functional associations with colorectal neoplasia presence, severity (non-advanced, advanced and CRC) and subtype and evaluate predictive potential in high-risk neoplasia. DESIGN: Analysed cross-sectional stool metagenomes (pre-colonoscopy) from 1762 participants (97% White British) undergoing colonoscopy in the multicentre COLO-COHORT study. Neoplasia was classified per British Society of Gastroenterology surveillance guidelines. Linear mixed-effects models and random forest classifiers assessed taxonomic and functional associations, adjusting for dietary, clinical and lifestyle covariates. RESULTS: Gut microbiome composition differences between individuals with and without neoplasia were statistically significant but minimal (R2=0.0008, p=0.03). A small number of species, including Mediterraneibacter faecis and Pseudoruminococcus massiliensis, and microbial pathways, including amino acid biosynthesis and β-lactam resistance, were modestly linked to neoplasia, particularly early lesions (q value <0.05). Associations were generally weak and attenuated after covariate adjustment. Predictive models combining the microbiome with clinical/demographic features modestly improved high-risk neoplasia classification (area under the curve=0.64 vs 0.58 for clinical/demographic features alone). CONCLUSION: This large prospective cross-sectional study found weak and inconsistent associations between the gut microbiome and premalignant colorectal neoplasia, with no robust microbial signatures. Findings suggest that previously reported microbial shifts may emerge later in disease progression, potentially as a consequence rather than a cause of CRC. Longitudinal, multiomic studies disentangling temporal and causal pathways between the gut microbiome and neoplasia are required.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Louca P, Manning S, Hackney E, et al. Gut microbiome signatures in colorectal neoplasia: a cross-sectional study across neoplasia stages and subtypes. Gut. 2026. PMID: 41791848. doi:10.1136/gutjnl-2025-337478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。